Advertisements


Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon.....»»

Category: earningsSource: benzingaApr 16th, 2018

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results

-Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of Clinical Trials for CTX001 in β-thalassemia and SCD on Track for 2018--Preclinical Studies for CTX110 Targeting CD19+ Malignancies Ha.....»»

Category: earningsSource: benzingaAug 7th, 2018

Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results

WARREN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ.....»»

Category: earningsSource: benzingaAug 1st, 2018

Unum Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update

– Successfully Completed IPO and Concurrent Private Placement Raising $77 Million in Gross Proceeds – – Initiated Cohort Expansion of ATTCK-20-2 Phase I T.....»»

Category: earningsSource: benzingaMay 14th, 2018

Galectin Therapeutics Reports 2018 First Quarter Financial Results and Provides Business Update

NORCROSS, Ga., May 11, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial re.....»»

Category: earningsSource: benzingaMay 11th, 2018

Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results

WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today prov.....»»

Category: earningsSource: benzingaMay 10th, 2018

CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update

CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaSep 21st, 2018

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update.....»»

Category: earningsSource: benzingaSep 13th, 2018

ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update

Conference call and webcast scheduled for Tuesday, September 11that 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmed Phase 3 trial for eryaspase in second line pan.....»»

Category: earningsSource: benzingaSep 10th, 2018

Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan™

Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan™ PR Newswire WARREN, N.J., Sept. 4, 2018 WARREN, N.J., Sept. 4, 20.....»»

Category: earningsSource: benzingaSep 4th, 2018

Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update

VICTORIA, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH, OTCQX:EMHTF) ("Emerald" or "the Co.....»»

Category: earningsSource: benzingaAug 30th, 2018

NuCana Reports Second Quarter 2018 Financial Results and Provides Business Update

EDINBURGH, United Kingdom, Aug. 28, 2018 (.....»»

Category: earningsSource: benzingaAug 28th, 2018

Therapix Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update

Therapix Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update PR Newswire TEL AVIV, Israel, Aug. 20, 2018 TEL AVIV, Israel, Aug. 20.....»»

Category: earningsSource: benzingaAug 20th, 2018

Hemispherx Reports Six Months Ended June 30, 2018 Financial Results and Provides Business Update

OCALA, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB), an immuno-pharma R&D and eme.....»»

Category: earningsSource: benzingaAug 15th, 2018

SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2018 Financial Results

NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of novel.....»»

Category: earningsSource: benzingaAug 15th, 2018

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results -Ongoing Exploration of Strategic Opportunities- -Continued Progress in Stem-to-T-Cell.....»»

Category: earningsSource: benzingaAug 13th, 2018

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

Category: earningsSource: benzingaAug 13th, 2018

Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

Regenerative Medicin.....»»

Category: earningsSource: benzingaAug 13th, 2018

AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ:AVRO) (the "Company"), a Phase 2 clinical stage gene therap.....»»

Category: earningsSource: benzingaAug 9th, 2018

Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

Audentes Therapeutics Reports Seco.....»»

Category: earningsSource: benzingaAug 7th, 2018

EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage, specialty pharmac.....»»

Category: earningsSource: benzingaAug 3rd, 2018